Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
1.470
+0.080 (5.76%)
Nov 28, 2025, 1:00 PM EST - Market closed
Neuronetics Market Cap
Neuronetics has a market cap or net worth of $100.67 million as of November 28, 2025. Its market cap has increased by 380.78% in one year.
Market Cap
100.67M
Enterprise Value
164.82M
1-Year Change
380.78%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since June 28, 2018, Neuronetics's market cap has decreased from $464.84M to $100.67M, a decrease of -78.34%. That is a compound annual growth rate of -18.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 102.04M | 13.89% |
| Dec 31, 2024 | 89.60M | 6.79% |
| Dec 29, 2023 | 83.91M | -55.13% |
| Dec 30, 2022 | 187.01M | 59.02% |
| Dec 31, 2021 | 117.60M | -44.22% |
| Dec 31, 2020 | 210.82M | 151.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 287.99B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |